Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05872347
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2023-05-14
Brief Title:
Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases
Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Organization Data
Organization:
Shanghai Pharmaceuticals Holding Co Ltd
Class:
INDUSTRY
Study ID:
SPH4336-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shanghai Pharmaceuticals Holding Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None